Background: Recent data suggest sentinel lymph node biopsy (SLNBx) for invasive breast
cancer (IBC) is widely performed in the United States, often outside of a clinical trial. We …

Sentinel lymph node biopsy (SLNB) in breast cancer has not been readily adopted into
Canadian surgical practice in comparison with the United States. We sought to evaluate …

Introduction There is a lack information regarding how sentinel lymph node biopsy (SLNB)
for breast cancer is carried out today in developing countries and how it was adapted. To …

Background: Ongoing clinical trials are addressing the accuracy and safety of sentinel node
biopsy (SNB) in the treatment of breast cancer; however, SNB is already increasingly being …

Background The quality SLNB for breast cancer has never been evaluated on a population
level. We previously developed SLNB quality indicators (QIs) and measured them at a single …

Sentinel lymph node biopsy (SLNB) for breast cancer is now performed routinely in many
US medical centers. The acceptance of SLNB in the community and in rural medical centers …

Breast cancer is the most commonly diagnosed cancer in Ontario for women, accounting for
almost 29% of all female incident cases (2). In Ontario, the guidelines for the surgical …

BACKGROUND: We sought to determine whether the results of sentinel lymph node (SLN)
biopsy are related to practice and community factors. METHODS: This prospective study …

Background: Sentinel lymph node biopsy (SLNB) for the evaluation of women with invasive
breast cancer is rapidly gaining acceptance. The purpose of this study was to assess how …

Background Sentinel lymph node biopsy (SNLB) has been adopted as the standard method
of axillary staging for women with clinically node-negative early-stage breast cancer. The …